bpc-157 human clinical trials safety BPC-157: Experimental Peptide Creates Risk for Athletes bpc-157 clinical trial safety bpc

Peptides for menopause symptom management may complement tirzepatide therapy in perimenopausal and postmenopausal women

My book, Hashimotos Protocol , goes further in depth on strategies for getting to the root cause of your thyroid disorder and addressing nutrient deficiencies so you can start feeling better

Distract and reassure

Spotting when wiping during perimenopause is common, affecting around 4050% of women who track their cycles during this transition Hormonal fluctuations, particularly estrogen and progesterone shifts, cause most perimenopausal spotting Conditions like uterine fibroids, polyps, and vaginal atrophy can also trigger spotting Tracking symptoms helps identify patterns and provides valuable information for healthcare providers Heavy bleeding, severe pain, or spotting after menopause requires prompt medical evaluation Finding blood when wiping can feel alarming, especially when periods become unpredictable

They are available from as small as a 27 gauge unit (0.42 mm), going up to 14 gauge (1.83 mm)